BGB-B2033
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGB-B2033, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors [Phase 1]